<DOC>
	<DOC>NCT00909428</DOC>
	<brief_summary>Evaluating the effect of VesicareR 10 mg (Solifenacin, Astellas Inc) QD, on the urgency level as recorded by the filling phase of urodynamic testing, in patients with overactive bladder. In this pilot study, 10 patients with overactive bladder syndrome (OAB) symptoms and who have previously undergone urodynamic testing which demonstrated detrusor overactivity and who are not currently receiving an anticholinergic drug, will be recruited from our clinic. Patients will take Vesicare 10 mg daily for 1 month, then undergo repeat urodynamic testing for repeat evaluation of the urgency level during the filling phase.</brief_summary>
	<brief_title>Validation of a Real-Time Urodynamic Measure of Urinary Urgency</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Have symptoms of urge or mixed incontinence (urge predominant) and desire treatment with anticholinergic medication. Symptoms are established by responses to the MESA questionnaire, already completed as part of routine clinical care. Demonstrated detrusor overactivity with or without incontinence during urodynamic testing, during routine clinical care. Are able to consent and fill out study documents, complete repeated urodynamic testing and follow up in 4 weeks. Have been treated with any anticholinergic medication in the previous month. Have an elevated post void residual volume as determined during their routine clinical care. Have had a urinary tract infection in the last month, as determined by history. Have untreated narrow angle glaucoma, by patient history. Have a known allergy or intolerance to VesicareR, as determined by patient history.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>overactive bladder syndrome</keyword>
	<keyword>lower urinary tract</keyword>
	<keyword>urgency</keyword>
	<keyword>solifenacin</keyword>
	<keyword>pharmacotherapy</keyword>
	<keyword>urodynamic testing</keyword>
</DOC>